Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence

被引:9
|
作者
Chan, C. K. [1 ]
Wong, K. H. [2 ]
Lee, M. P. [3 ]
Chan, Kenny C. W. [4 ]
Leung, C. C. [1 ]
Leung, Eric C. C. [1 ]
Chan, W. K. [4 ]
Mak, Ida K. Y. [1 ]
机构
[1] Dept Hlth, TB & Chest Serv, Ctr Hlth Protect, Hong Kong, Hong Kong, Peoples R China
[2] Dept Hlth, Ctr Hlth Protect, Head Off, Hong Kong, Hong Kong, Peoples R China
[3] Hosp Author, Dept Med, Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Dept Hlth, Ctr Hlth Protect, Integrated Treatment Ctr, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; DEATH; DETERMINANTS; ADULTS;
D O I
10.12809/hkmj187303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Data are limited regarding risk factors for mortality among patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) in areas with low HIV prevalence and intermediate TB burden, such as the Western Pacific region. This study aimed to assess such risk factors in Hong Kong, which has an intermediate TB burden and low HIV prevalence. Methods: We conducted a retrospective cohort analysis of adult patients reported to the Hong Kong TB-HIV Registry between 2006 and 2015. Baseline characteristics were compared with Kaplan-Meier estimates. Cox proportional hazards regression modelling was used to identify factors associated with mortality. Results: Of 299 patients studied, 21 (7.0%) died within 12 months of anti-TB treatment (median [interquartile range], 7.5 [3.8-10] months). The median age of death was 54 (interquartile range, 40.5-75.0) years. The cause of death was TB in five and unrelated to TB in the remaining 16. Cox proportional hazards regression showed that older age (adjusted hazard ratio=4.5; 95% confidence interval [CI]=1.4-14.9), history of drug addiction (4.6; 95% CI=1.6-13.0), and low baseline CD4 cell count of <50/mu L (2.9; 95% CI=1.1-7.7) were independent risk factors for death within 12 months. Conclusion: This study complements previous studies by providing information regarding risk factors associated with mortality among patients with HIV-associated TB in areas with intermediate TB burden and low HIV prevalence. The results from our study may guide targeted measures to improve survival in other areas with intermediate TB burden and low HIV prevalence, such as the Western Pacific region.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 50 条
  • [41] Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie, Ethiopia
    Wondwosen Mebratu
    Shambel Wedajo
    Semira Mohammed
    Abel Endawkie
    Yeshiwork Damtew
    [J]. Scientific Reports, 12
  • [42] Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie, Ethiopia
    Mebratu, Wondwosen
    Wedajo, Shambel
    Mohammed, Semira
    Endawkie, Abel
    Damtew, Yeshiwork
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
    Kerkhoff, Andrew D.
    Wood, Robin
    Lawn, Stephen D.
    [J]. AIDS, 2011, 25 (07) : 1003 - 1006
  • [44] Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China
    Xue, Ming
    Xie, Ruming
    Pang, Yu
    Yan, Shuo
    Du, Yanni
    Guan, Chunshuang
    Chen, Budong
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [45] Collaborative activities and treatment outcomes in patients with HIV-associated tuberculosis in Viet Nam
    Huyen, T. T. T.
    Nhung, N. V.
    Shewade, H. D.
    Hoa, N. B.
    Harries, A. D.
    [J]. PUBLIC HEALTH ACTION, 2016, 6 (01): : 8 - 14
  • [46] Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China
    Ming Xue
    Ruming Xie
    Yu Pang
    Shuo Yan
    Yanni Du
    Chunshuang Guan
    Budong Chen
    [J]. BMC Infectious Diseases, 20
  • [47] Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis: A Reply
    Lawn, Stephen D.
    Wood, Robin
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) : 341 - 342
  • [48] FACTORS ASSOCIATED WITH MORTALITY AMONG TUBERCULOSIS PATIENTS IN SOUTHEAST TURKEY
    Yilmaz, Sureyya
    Taylan, Mahsuk
    Sen, Hadice Selimoglu
    Abakay, Ozlem
    Demir, Melike
    Kaya, Halide
    Yilmaz, Zulfukar
    Topcu, Fusun
    [J]. ACTA MEDICA MEDITERRANEA, 2015, 31 (06): : 1241 - 1246
  • [49] Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa
    Lawn, Stephen D.
    Campbell, Lucy
    Kaplan, Richard
    Boulle, Andrew
    Cornell, Morna
    Kerschberger, Bernhard
    Morrow, Carl
    Little, Francesca
    Egger, Matthias
    Wood, Robin
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (02) : 136 - 140
  • [50] HIV prevalence among tuberculosis patients in The Netherlands, 1993-2001: trends and risk factors
    Haar, C. H.
    Cobelens, F. G. J.
    Kalisvaart, N. A.
    Van der Have, J. J.
    Van Gerven, P. J. H. J.
    Van Deutekom, H.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (07) : 768 - 774